TNGX — Tango Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.83bn
- $2.81bn
- $62.38m
Tango jumps after $225 million capital raise
Brief: Healthcare Veteran David Wilkinson To Join Tango As Chief Financial Officer
Tango Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Tango Therapeutics Q2 revenue drops, net loss widens
Tango Therapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: Tango Therapeutics Announces First Patient Dosed In Phase 1/2 Trial Of Tng462 Plus Revolution Medicines’ Daraxonrasib
Brief: Tango Therapeutics Files For Mixed Shelf Of Up To $400 Million
Tango Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Tango Therapeutics Q1 Basic EPS USD -0.36
Tango Therapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview
Tango Therapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: Tango Therapeutics Q4 Basic EPS USD -0.35
Brief: Tango Therapeutics Q3 Basic EPS USD -0.27
Brief: Tango Therapeutics Reports Positive TNG462 Clinical Data And Provides Update On PRMT5 Development Program
Brief: Tango Therapeutics Q2 Basic EPS USD -0.24
Tango Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-International Paper, Liveramp, Ralph Lauren
U.S. STOCKS ON THE MOVE-Synopsys, CSW Industrials, Take-Two Interactive
U.S. STOCKS ON THE MOVE-Nvidia, Hasbro, News Corp